Foreign investors divested ₹4,521 crore from IT and ₹4,036 crore from healthcare stocks in the latter half of September. This selling was driven by concerns over US H-1B visa restrictions and new pharma tariffs, impacting export-oriented sectors. Overall, FPIs sold ₹19,647 crore across 15 sectors (...)
Site référencé: The Economic Times
The Economic Times
PepsiCo's new challenge : Making its chips and sodas colorful without artificial dyes
2/10/2025
Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say
2/10/2025
WeWork India IPO : Can investors tag along India's booming Rs 50,000 crore flex space market ?
2/10/2025
Procter & Gamble will shut down business in Pakistan, following Shell and Pfizer exits
2/10/2025
Dubai real estate market 2025 : A thriving global investment hub
2/10/2025
Only 9.5% of Indian households invest despite 63% market awareness : Sebi survey
2/10/2025
